4 completed, 3 unknown, 1 not yet recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Lin Chen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Observational Cohort Study observation - Gastric Cancer, Liver Metastases | Not yet recruiting | Lin Chen | 1326 | 2024-07-15 | 2024-07-10 | |
| Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer Tirolizumab+SOX/XELOX, SOX/XELOX - Locally Advanced Gastric Carcinoma, HER2 Negative | Phase 2 | Unknown | Lin Chen | 80 | 2023-10-01 | 2024-02-29 |
| Aspergillosis Detection Via EBC-GM in Ventilated Patients Compare the levels of Galactomannan (GM) levels in exhaled breath condensate (EBC) and BALF - Bronchoalveolar Lavage Fluid, Sensitivity and Specificity | Completed | Lin Chen | 75 | 2023-01-02 | 2024-03-27 | |
| Risk of Aspergillus Infection in Patients With Chronic Lung Disease No intervention - Fungal Infection Lungs | Completed | Lin Chen | 209 | 2022-07-01 | 2024-04-23 | |
| Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer Measurement of levels of circulating exosomal lncRNA-GC1 - Gastric Cancer | Unknown | Lin Chen | 700 | 2022-05-01 | 2022-06-27 | |
| Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes esmolol - Sepsis, Lymphocyte Disorder T | Phase 2 | Completed | Lin Chen | 150 | 2021-01-01 | 2024-05-29 |
| Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy Circulating exosomal lncRNA-GC1 detection - Advanced Gastric Carcinoma, Immunotherapy | Completed | Lin Chen | 80 | 2018-11-01 | 2022-10-12 | |
| SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer Oxaliplatin+S-1, Adjuvant Oxaliplatin/S-1（SOX） - Gastric Adenocarcinoma | Phase 3 | Unknown | Lin Chen | 772 | 2012-03-01 | 2012-04-24 |
Stomach Neoplasms (2) · Autonomic Nervous System Diseases (1) · Critical Illness (1) · Cytokine Release Syndrome (1) · Disease Progression (1) · Hypersensitivity (1) · Invasive Pulmonary Aspergillosis (1) · Respiratory Insufficiency (1) · Sepsis (1)
Floors and Floorcoverings (1) · Observation (1) · esmolol (1)
China (8)
Qiying Song, MD (1)
PMID 33538338, PMID 38240494, PMID 38589926, PMID 38954860, PMID 39779263, PMID 40421209, PMID 40654578